ABSTRACT
BACKGROUND:
All-trans retinoic acid (ATRA) is a vitamin A derivative that is used in combination with chemotherapy to treat acute promyelocytic leukemia (APL). A serious complication of ATRA is retinoic acid syndrome (RAS), which is characterized by an inflammatory reaction with capillary leakage and myeloid cell tissue invasion that presents with cardiopulmonary symptoms and occasionally acute kidney injury.
CASE-DIAGNOSIS/TREATMENT:
We report the case of a 3-year-old child with APL who developed transient nephrotic-range proteinuria (max urine protein:creatinine ratio 8.6) during two episodes of RAS while on ATRA therapy. ATRA was temporarily discontinued and the patient was treated with a 3-day course of dexamethasone during each episode. He maintained normal renal function throughout and the proteinuria completely resolved.
CONCLUSIONS:
This is the first reported occurrence of nephrotic-range proteinuria in a child treated with ATRA. Nephrologists should be aware that RAS is a serious complication of ATRA that may lead to proteinuria.
Nephrotic-range proteinuria in a child with retinoic acid syndrome
Riferimento:
Pediatr Nephrol. 2012 Mar;27(3):485-8.
Autori:
Sethna CB, Reddy K, Fein-Levy C, Trachtman H. csethna@nshs.edu
Fonte:
Pediatr Nephrol. 2012 Mar;27(3):485-8.
Anno:
2012
Azione:
Insorgenza di proteinuria di origine nefrosica in un bambino, con leucemia promielocitica acuta (APL), trattato con acido all-trans retinoico (ATRA).
Target:
ATRA/proteinuria in APL.
Sostanze:
